Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Neprilysin - Pipeline Review, H2 2016 - Key Vendors are Bioprojet, Novartis & Pharmaleads - Research and Markets

Research and Markets
Posted on: 26 Oct 16

Research and Markets has announced the addition of the "Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Neprilysin, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neprilysin and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Bioprojet SCR
  • Novartis AG
  • Pharmaleads SA
  • Theravance Biopharma, Inc.

Key Topics Covered:

  1. Introduction
  2. Neprilysin Overview
  3. Therapeutics Development
  4. Pipeline Products for Neprilysin - Overview
  5. Pipeline Products for Neprilysin - Comparative Analysis
  6. Neprilysin - Therapeutics under Development by Companies
  7. Neprilysin - Therapeutics under Investigation by Universities/Institutes
  8. Neprilysin - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Neprilysin - Products under Development by Companies
  13. Neprilysin - Products under Investigation by Universities/Institutes
  14. Neprilysin - Companies Involved in Therapeutics Development

For more information about this report visit

View source version on

Business Wire

Last updated on: 26/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.